PROSTAGLANDIN AQUEOUS EYE DROP
PROBLEM TO BE SOLVED: To make it possible to suppress a pH decrease with time and suppress even lowering of the residual ratio of an active ingredient in an aqueous eye drop of prostaglandins using boric acid and a specific nonionic surfactant. SOLUTION: The preservative-free and boric acid buffer-b...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To make it possible to suppress a pH decrease with time and suppress even lowering of the residual ratio of an active ingredient in an aqueous eye drop of prostaglandins using boric acid and a specific nonionic surfactant. SOLUTION: The preservative-free and boric acid buffer-based eye drop of the prostaglandins comprises the prostaglandins such as latanoprost or isopropylunoprostone as the active ingredient (chief ingredient) and is regulated to pH5.0-7.0. POE caster oil and/or POE hardened caster oil and/or monostearic acid PEG are used as a solubilizer for the prostaglandins. The pH is stabilized by adding an aminocarboxylic acid having a chelating ability such as ethylenediaminetetraacetic acid (including a salt) or -aminocaproic acid. COPYRIGHT: (C)2008,JPO&INPIT |
---|